改善质母细胞瘤患者生存的新方法:整合性瘤学的长度试点研究
Massimo Bonucci1, Maria Pia Fuggetta2, Lorenzo Anelli1
1Association for Research on Integrative Oncology Therapies (ARTOI) Foundation, 00165 Rome, Italy.
Cancers
|July 29, 2025
概括
使用多达丁,黄素和Boswellia serrata等天然化合物的综合疗法可能会延长接受标准治疗的质母细胞瘤 (GBM) 患者的生存期. 坚持这种整合疗法 (IT) 显示出更好的结果,特别是粗整体切除.
科学领域:
- 神经瘤学神经瘤学
- 综合性瘤学是一种综合性瘤学.
- 临床研究是临床研究.
背景情况:
- 质母细胞瘤 (GBM IDH-野生型WHO 2021) 是一种高度侵袭性的脑癌,治疗选择有限.
- 临床前研究表明,天然化合物可以增强标准质母细胞瘤疗法.
- 除了标准护理之外,研究补充疗法对于改善患者的治疗结果至关重要.
研究的目的:
- 评估接受标准治疗加上综合治疗 (IT) 的质母细胞瘤患者的生存结果.
- 评估IT遵守对整体生存时间 (OS) 的影响.
- 确定质母细胞瘤患者延长生存的预测因素.
主要方法:
- 对72名新诊断的质母细胞瘤患者进行前性纵向观察试点研究.
- 患者接受了标准的STUPP协议治疗;一些人自愿添加综合疗法 (聚达丁,黄素,Boswellia serrata).
- 对IT附属和非附属组的生存结果进行比较;多变量考克斯回归调整以考虑混因素.
主要成果:
- 整个队列的中位数OS为13.3个月.
- 坚持IT的患者 (n=60) 的平均寿命为25.4个月 (34.4个月与总切除).
- 非IT患者 (n=12) 的平均寿命为10.6个月;IT坚持和切除程度是生存的独立预测指标.
结论:
- 综合疗法 (聚达丁,黄素,Boswellia serrata) 与标准治疗相结合,似乎与质母细胞瘤患者的寿命延长有关.
- 这些发现表明潜在的益处,特别是对于实现粗整体切除的患者.
- 由于研究的局限性 (小对照组,没有随机化),需要通过随机对照试验进行进一步的验证.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


